EXECUTIVE ENGAGEMENTS
OUTREACH
403
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
81
Interactions with Platform & by Email
PARTICIPANTS
16
Unique # Participated
VALIDATIONS
7
Responses Validated*
COMPETITORS
47
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
153
PAGES
230
EDITION
6
PRICE
USD $4950
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Single Photon Emission Computed Tomography (SPECT) estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Cardiology, one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$762.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oncology segment is readjusted to a revised 5.1% CAGR for the next 7-year period.
The Single Photon Emission Computed Tomography (SPECT) market in the U.S. is estimated at US$390.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$324.4 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
In the global General Imaging segment, USA, Canada, Japan, China and Europe will drive the 3.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$270.3 Million in the year 2020 will reach a projected size of US$346.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$204.3 Million by the year 2027.
SELECT PLAYERS
Bruker Corporation; Digirad Corporation; Esaote SpA; GE Healthcare; Invicro, LLC; Mediso Medical Imaging Systems ; MR Solutions Ltd.; Philips Healthcare; Siemens Healthineers; Trifoil Imaging, Inc.
SEGMENTS
» Application (Cardiology, Oncology, General Imaging, Neurology) » End-Use (Hospitals, Diagnostic Centers and Clinics, Academic and Research Centers) » Product Type (Standalone SPECT, Hybrid SPECT)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for SPECT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for General Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for General Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for General Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Standalone SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Standalone SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Standalone SPECT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hybrid SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hybrid SPECT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hybrid SPECT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Diagnostic Centers and Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Diagnostic Centers and Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Diagnostic Centers and Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Academic and Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Academic and Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Academic and Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for SPECT by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for SPECT by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for SPECT by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for SPECT by Application - Cardiology, Oncology, General Imaging and Neurology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for SPECT by Application - Percentage Breakdown of Value Sales for Cardiology, Oncology, General Imaging and Neurology for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for SPECT by Product Type - Standalone SPECT and Hybrid SPECT - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for SPECT by Product Type - Standalone SPECT and Hybrid SPECT Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for SPECT by Product Type - Percentage Breakdown of Value Sales for Standalone SPECT and Hybrid SPECT for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for SPECT by End-Use - Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for SPECT by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers and Clinics and Academic and Research Centers for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 47 |
It Pays to Understand the Dynamics of Competition in Your Business Ecosystem.
Who Are Your Competitors in the SPECT Market?
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com